• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.67% Nasdaq Up 1.47%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    5.54 Up 0.35(6.74%) 4:00PM EDT
    |After Hours : 5.54 0.00 (0.00%) 4:22PM EDT
    Add to Portfolio
    Prev Close:5.19
    Open:5.37
    Bid:4.80 x 100
    Ask:5.75 x 200
    1y Target Est:8.67
    Beta:2.81
    Earnings Date:Aug 6 - Aug 10 (Est.)
    Day's Range:5.29 - 5.66
    52wk Range:3.31 - 7.84
    Volume:1,105,734
    Avg Vol (3m):961,438
    Market Cap:385.83M
    P/E (ttm):123.11
    EPS (ttm):0.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PGNX

    Comparison

    Symbol% ChgMkt Cap
    PGNXUp 6.74%385.83M
    DNDN 0.00%N/A
    NKTRUp 0.17%1.52B

    Key Statistics

    Forward P/E (1 yr):277.00
    P/S (ttm):8.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.54
    Quarterly EPS Est (Jun-15) :-0.15
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-0.41

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. The company’s primary clinical-stage product candidates include prostate specific membrane antigen (PSMA) antibody-drug conjugate, which... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback